Akili Interactive Labs Inc. has a struck a $125m deal with Japanese pharmaceutical firm Shionogi & Co. Ltd. to commercialize two of its product candidates in Japan and Taiwan.
Boston-based Akili, is the developer of digital therapeutics and diagnostics that look and feel like video games to treat children with cognitive disorders. The company, a subsidiary of PureTech...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?